Precision Cancer Biology and Medicine

The conference will cover the latest exciting developments in our detailed understanding of the biology and genomics of cancer and the important translation of this understanding into personalized, precision treatment for cancer patients. It will include eight oral sessions and one poster session covering new findings across a wide range topics in basic cancer biology, genetics, genomics and medicine. Therapeutic aspects will include molecular targeted drugs and immunological approaches together with the mechanisms and treatment of drug resistance. In addition, many talks will be selected from the openly submitted abstracts on the basis of scientific merit and relevance to the theme of the conference. Social events organized throughout the conference will provide ample opportunity for informal interactions between speakers and other attendees.
+ show speakers and program
Major Topics:
1. Oncoproteins and Cellular Targets
2. Gastrointestinal and Hepatobiliary Malignancies
3. Emerging Concepts and Technologies
4. Target Identification and Therapeutic Discovery
5. Integrative Science and Translation
6. Genomics, Biomarkers and clinical trials

Confirmed Keynote Speakers
Arul Chinnaiyan, HHMI/University of Michigan Medical School, USA
Title: The Application of Integrative Sequencing for Precision Medicine
Yang Shi, Harvard Medical School, USA
Title: Histone Methylation, Recognition and Link to Human Disease
Confirmed Invited Speakers
Andrew Biankin, University of Glasgow, UK
Title: Pancreatic Cancer Genomics in the Clinic
Fan Bai, Peking University, China
Title: Single Cell Genomic Characterization of Circulating Tumor Cells
Andrea Califano, Columbia University, USA
Title:TBA
Rebecca Fitzgerald, Medical Research Council, UK
Title: Harnessing Genomic Information for Early Diagnosis and Risk Stratification of Oesophageal Adenocarcinoma
Andrew Futreal, The University of Texas MD Anderson Cancer Center, USA
Title: From Data to Science to Medicine
Joe Gray, Oregon Health & Science University, USA
Title: Linking the Ome to Multiscale Structure in Cancer
Mao Mao, Wuxi AppTec, China
Title: Lung Cancer Gene Fusion Diagnosis and Targeted Therapies
Alex Matter, A*STAR, Singapore
Title: Bridging Academic Science and Clinical Research in the Search for Novel Targeted Anti-cancer Agents
Tony Mok, CUHK in Prince of Wales Hospital, China
Title: Cutting Edge Personalized Therapy for Lung Cancer in 2015: Including Application of Blood-based Genomic testing
Seishi Ogawa, University of Tokyo, Japan
Title: Molecular Profiling of Human Cancer
Hideyuki Saya, Keio University, Graduate School of Medicine, Japan
Title: Development of Cancer Stem Cell Targeting Therapies
Er-Wei Song, Sun Yat-sen University, China
Title: Signaling Protein Interacting Long Non-coding RNAs Regulate Breast Cancer Metastasis
Charles Swanton, London Research Institute, UK
Title: Spatial and Temporal Tumour Evolution: Implications for Precision Medicine
Patrick Tan, Genome Institute of Singapore, Singapore
Title: Genomic Profiles of Asian-Endemic Cancers
Daniel G. Tenen, Cancer Science Institute of Singapore, Singapore
Title: TBA
Cun-Yu Wang, University of California, Los Angeles, USA
Title: Epigenetic Control of Squamous Cell Carcinoma Invasive Growth and Metastasis
Paul Workman, The Institute of Cancer Research, London, UK
Title: Drugging the Cancer Genome
Timothy Yap, The Institute of Cancer Research and Royal Marsden, UK
Title: TBA
Qiang Yu, Genome Institute of Singapore, Singapore
Title: New Insights in Molecular Pathways and Therapeutic Implications in Breast Cancer Metastasis
Yinyin Yuan, The Institute of Cancer Research, UK
Title: Ecological Modeling of Cancer and Cancer Therapy
Qi Zeng, Institute of Molecular and Cell Biology, Singapore
Title: Tapping Intracellular Oncoproteins for Precision Cancer Medicine
Qimin Zhan, Peking Union Medical College, China
Title: Genomic Landscape of Esophageal Squamous Cell Carcinoma (ESCC)

4 May - 4 May 2015
suzhou
China
meeting website